155 results
8-K
EX-99.1
BTAI
BioXcel Therapeutics Inc
9 May 24
BioXcel Therapeutics Reports First Quarter 2024 Financial Results
7:12am
.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act
8-K
EX-99.1
BTAI
BioXcel Therapeutics Inc
22 Apr 24
Regulation FD Disclosure
7:10am
Securities Litigation Reform Act of 1995 . BioXcel Therapeutics, Inc . (“BioXcel” or the “Company”) intends such forward - looking statements to be covered
8-K
BTAI
BioXcel Therapeutics Inc
22 Apr 24
Regulation FD Disclosure
7:10am
“forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements
8-K
pwth7h980 b9q9417x
10 Apr 24
Regulation FD Disclosure
7:05am
8-K
EX-99.1
tonvdg er
10 Apr 24
Regulation FD Disclosure
7:05am
8-K
EX-10.1
av5skk
25 Mar 24
Entry into a Material Definitive Agreement
4:05pm
8-K
7fqvd s1skl
25 Mar 24
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-99.1
fcqp 8o97
12 Mar 24
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
7:15am
8-K
EX-99.1
3485j 7oa1
14 Feb 24
Regulation FD Disclosure
7:00am
8-K
mti3k
8 Feb 24
Other Events
4:53pm
8-K
EX-10.1
ydcm2si
8 Feb 24
Other Events
4:53pm
8-K
mpi9c6p7bhyeqd4 dd
8 Feb 24
Other Events
7:08am